RenovoRx annual operating margin
2024
2025
RenovoRx Operating Margin Growth & History (RNXT)
RenovoRx's operating margin was −1,113.98% for fiscal 2025.
View full RenovoRx company overviewRenovoRx annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,113.98% | +24397.65 pp |
| 2024 | 2024-12-31 | −25,511.63% | — |
RenovoRx quarterly operating margin
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −368.43% | +266.17 pp |
| Q1 2026 | 2026-03-31 | −616.16% | +962.52 pp |
| Q4 2025 | 2025-12-31 | −1,479.83% | — |
| Q3 2025 | 2025-09-30 | −1,203.01% | — |
| Q2 2025 | 2025-06-30 | −634.60% | — |
| Q1 2025 | 2025-03-31 | −1,578.68% | — |
RenovoRx operating margin trends
Across the available reported history, RenovoRx's operating margin increased from −25,511.63% to −1,113.98%, a change of +24397.65 percentage points. The latest reported quarter, Q2 2026, shows −368.43%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RenovoRx filings at SEC.gov ↗